Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Richard Charles Coulon | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Jack Arbiser | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | 12 Jahre |
Stephen M. Martin | M | 77 |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Geoff Meacham | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
R. Jason Thomas | M | - |
Accuitis, Inc.
Accuitis, Inc. Pharmaceuticals: MajorHealth Technology Accuitis, Inc. operates as a pre-clinical-stage biopharmaceutical company. It develops first-in-class drug therapies to treat chronic diseases of the skin and eye. The firm engages in the acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states. The company was founded on December 13, 2011 and is headquartered in Alpharetta, GA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 5 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mike Shippel
- Persönliches Netzwerk